Lenacapavir administered every 26 weeks or daily in combination with oral daily antiretroviral therapy for initial treatment of HIV: a randomised, open-label, active-controlled, phase 2 trialSamir K. Gupta, Ellen Koenig, Mezgebe Berhe et al.|The Lancet HIV|2022Cited by 107
Fermi surface sheet-dependent band splitting in Sr<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:msub><mml:mrow/><mml:mn>2</mml:mn></mml:msub></mml:math>RuO<mml:math xmlns:mml="http://www.w3.org/1998/Math/MathML" display="inline"><mml:msub><mml:mrow/><mml:mn>4</mml:mn></mml:msub></mml:math>revealed by high-resolution angle-resolved photoemission spectroscopyShanyu Liu, Xingjiang Zhou, Quansheng Wu et al.|Physical Review B|2012Cited by 10